Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1369-1373

  Chen, Zhihua ^a   Lai, Xianliang ^a   Song, Shuxin ^a   Zhu, Xingen ^a   Zhu, Jianming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Combination therapy; gene therapy; gliomatosis cerebri; nanostructured lipid carriers

Indexed keywords

DNA; DRUG CARRIER; LIPOFECTAMINE; NANOSTRUCTURED LIPID CARRIER; TEMOZOLOMIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DACARBAZINE; LIPID; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GENETIC LOAD; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL LINE; GLIOMATOSIS CEREBRI; GLIOSIS; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; TUMOR GROWTH; TUMOR VOLUME; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; GENETICS; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; NEOPLASMS, NEUROEPITHELIAL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DACARBAZINE; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; MICE; NANOMEDICINE; NANOSTRUCTURES; NEOPLASMS, NEUROEPITHELIAL; TRANSFECTION;

EID: 84975284905     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1038857     Document Type: Article

References (34)

1. X.Bao, W.Wang, C.Wang,. (2014). A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Biomaterials 35:8450–66
2. G.M.Bernal, M.J.LaRiviere, N.Mansour,. (2014). Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 10:149–57
3. G.D.Bothun, A.Lelis, Y.Chen,. (2011). Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomedicine 7:797–805
4. L.W.Buie, J.M.Valgus. (2012). Current treatment options for the management of glioblastoma multiforme. Hematol Oncol Pharm 2:57–63
5. N.Casagrande, M.De Paoli, M.Celegato,. (2013). Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. Gynecol Oncol 131:744–52
6. Y.H.Choi. (2014). Linoleic acid-induced growth inhibition of human gastric epithelial adenocarcinoma AGS cells is associated with down-regulation of prostaglandin E2 synthesis and telomerase activity. J Cancer Prev 19:31–8
7. S.Das, W.K.Ng, R.B.Tan. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51
8. D.W.Dong, B.Xiang, B.Gao,. (2013). pH-Responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials 34:4849–59
9. Y.Han, Y.Zhang, D.Li,. (2014). Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine 9:4107–16
10. A.Hejri, A.Khosravi, K.Gharanjig, M.Hejazi. (2013). Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem 141:117–23
11. T.L.Kaneshiro, Z.R.Lu. (2009). Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 30:5660–6
12. F.Kong, F.Zhou, L.Ge,. (2012). Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine 7:1079–89
13. LeathCA III, Straughn JM Jr. (2013). Chemotherapy for advanced and recurrent cervical carcinoma: results fromcooperative group trials. Gynecol Oncol 129:251–7
14. H.G.Lee, K.S.Lee, W.H.Lee, S.T.Kim. (2014). Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri. Brain Tumor Res Treat 2:102–17
15. H.S.Lee, E.D.Morrison, C.D.Frethem,. (2014). Cryogenic electron microscopy study of nanoemulsion formation from microemulsions. Langmuir 30:10826–33
16. B.Liu, S.M.Han, X.Y.Tang,. (2014). Cervical cancer gene therapy by gene loaded PEG-PLA nanomedicine. Asian Pac J Cancer Prev 15:4915–18
17. C.Liu, F.Liu, L.Feng,. (2013). The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials 34:2547–64
18. D.Ma, Q.M.Lin, L.M.Zhang,. (2014). A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery. Biomaterials 35:4357–67
19. K.Messaoudi, P.Saulnier, K.Boesen,. (2014). Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide. Int J Nanomedicine 9:1479–90
20. K.Morishima, T.Sato. (2014). Light scattering from hydrophobe-uptake spherical micelles near the critical micelle concentration. Langmuir 30:11513–19
21. R.H.Muller, M.Radtke, S.A.Wissing. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–55
22. A.Orza, O.Soriţău, C.Tomuleasa,. (2013). Reversing chemoresistance of malignant gliomas stem cells using gold nanoparticles. Int J Nanomedicine 8:689–702
23. K.Podolska, A.Stachurska, K.Hajdukiewicz, M.Małecki. (2012). Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med 21:525–34
24. C.Sarisozen, A.H.Abouzeid, V.P.Torchilin. (2014). The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Eur J Pharm Biopharm 88:539–50
25. A.Saupe, S.A.Wissing, A.Lenk,. (2005). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) – structural investigations on two different carrier systems. Bio-Med Mater Eng 15:393–402
26. W.R.Shapiro, J.R.Shapiro. (1998). Biology and treatment of malignant glioma. Oncology 12:233–40
27. F.Shi, G.Yang, J.Ren,. (2013). Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers. Int J Nanomedicine 8:2533–41
28. R.Stupp, M.E.Hegi, W.P.Mason,. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–66
29. O.Taratula, A.Kuzmov, M.Shah,. (2013). Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 171:349–57
30. R.Tiwari, K.Pathak. (2011). Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415:232–43
31. W.Yu, C.Liu, J.Ye,. (2009). Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology 20:215102
32. B.Yu, C.Tang, C.Yin. (2014). Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes. Biomaterials 35:6369–78
33. L.Yuan, C.Liu, Y.Chen,. (2013). Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int J Nanomedicine 8:4339–50
34. C.Zheng, M.Zheng, P.Gong,. (2013). Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterial 34:3431–8